Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kirschfink

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Blood|January 15, 1995
Striking inverse correlation between IgG anti-F(ab')2 and autoantibody production in patients with cold agglutinationP Terness, M Kirschfink, D Navolan, et al.
Clinical and Experimental Immunology|June 1, 1987
Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibodyR Burger, A Bader, M Kirschfink, et al.
European Journal of Anaesthesiology|July 28, 2005
Terminal complement complex in septic shock with capillary leakage: marker of complement activation?T Schuerholz, M Leuwer, M Cobas-Meyer, et al.
Complement and Inflammation|January 1, 1991
Differences in the complement activation induced by preformed and nascent immune complexesT Hidvégi, L Varga, A Falus, et al.
Parasitology Research|January 1, 1996
Circulating antigens in schistosomiasis: detection of 31/32-kDa proteins in sera from patients infected with Schistosoma japonicum, S. mansoni, S. haematobium, or S. intercalatumY L Li, M A Idris, M Corachan, et al.
Clinical and Experimental Immunology|December 2, 2008
Enhanced complement resistance in drug-selected P-glycoprotein expressing multi-drug-resistant ovarian carcinoma cellsK E Odening, W Li, R Rutz, et al.
Human Reproduction (Oxford, England)|April 29, 1998
Activated autologous blood therapy in recurrent spontaneous abortion--results of a pilot studyK A Pfeiffer, M Sillem, V Daniel, et al.
International Archives of Allergy and Immunology|January 1, 1993
Complement activation and C3 allotype distribution in patients with bronchial asthmaM Kirschfink, F F Castro, U Rother, et al.
Arthritis and Rheumatism|May 1, 1997
Antibodies against p53 in sera from patients with systemic lupus erythematosus and other rheumatic diseasesB Kovacs, A Patel, J N Hershey, et al.
Journal of Investigational Allergology & Clinical Immunology|October 20, 1998
SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patientsY Y Chiu, R M Nisihara, R Würzner, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Blood|January 15, 1995
Striking inverse correlation between IgG anti-F(ab')2 and autoantibody production in patients with cold agglutinationP Terness, M Kirschfink, D Navolan, et al.
Clinical and Experimental Immunology|June 1, 1987
Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibodyR Burger, A Bader, M Kirschfink, et al.
European Journal of Anaesthesiology|July 28, 2005
Terminal complement complex in septic shock with capillary leakage: marker of complement activation?T Schuerholz, M Leuwer, M Cobas-Meyer, et al.
Complement and Inflammation|January 1, 1991
Differences in the complement activation induced by preformed and nascent immune complexesT Hidvégi, L Varga, A Falus, et al.
Parasitology Research|January 1, 1996
Circulating antigens in schistosomiasis: detection of 31/32-kDa proteins in sera from patients infected with Schistosoma japonicum, S. mansoni, S. haematobium, or S. intercalatumY L Li, M A Idris, M Corachan, et al.
Clinical and Experimental Immunology|December 2, 2008
Enhanced complement resistance in drug-selected P-glycoprotein expressing multi-drug-resistant ovarian carcinoma cellsK E Odening, W Li, R Rutz, et al.
Human Reproduction (Oxford, England)|April 29, 1998
Activated autologous blood therapy in recurrent spontaneous abortion--results of a pilot studyK A Pfeiffer, M Sillem, V Daniel, et al.
International Archives of Allergy and Immunology|January 1, 1993
Complement activation and C3 allotype distribution in patients with bronchial asthmaM Kirschfink, F F Castro, U Rother, et al.
Arthritis and Rheumatism|May 1, 1997
Antibodies against p53 in sera from patients with systemic lupus erythematosus and other rheumatic diseasesB Kovacs, A Patel, J N Hershey, et al.
Journal of Investigational Allergology & Clinical Immunology|October 20, 1998
SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patientsY Y Chiu, R M Nisihara, R Würzner, et al.
Pageof 11